180 related articles for article (PubMed ID: 31545551)
1. Identification of Eph receptor signaling as a regulator of autophagy and a therapeutic target in colorectal carcinoma.
DiPrima M; Wang D; Tröster A; Maric D; Terrades-Garcia N; Ha T; Kwak H; Sanchez-Martin D; Kudlinzki D; Schwalbe H; Tosato G
Mol Oncol; 2019 Nov; 13(11):2441-2459. PubMed ID: 31545551
[TBL] [Abstract][Full Text] [Related]
2. The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis.
Martiny-Baron G; Holzer P; Billy E; Schnell C; Brueggen J; Ferretti M; Schmiedeberg N; Wood JM; Furet P; Imbach P
Angiogenesis; 2010 Sep; 13(3):259-67. PubMed ID: 20803239
[TBL] [Abstract][Full Text] [Related]
3. The Pyrazolo[3,4-
Neuber C; Tröster A; Löser R; Belter B; Schwalbe H; Pietzsch J
Molecules; 2020 Nov; 25(21):. PubMed ID: 33153234
[TBL] [Abstract][Full Text] [Related]
4. Eph-B2/ephrin-B2 interaction plays a major role in the adhesion and proliferation of Waldenstrom's macroglobulinemia.
Azab F; Azab AK; Maiso P; Calimeri T; Flores L; Liu Y; Quang P; Roccaro AM; Sacco A; Ngo HT; Zhang Y; Morgan BL; Carrasco RD; Ghobrial IM
Clin Cancer Res; 2012 Jan; 18(1):91-104. PubMed ID: 22010211
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells.
Megiorni F; Gravina GL; Camero S; Ceccarelli S; Del Fattore A; Desiderio V; Papaccio F; McDowell HP; Shukla R; Pizzuti A; Beirinckx F; Pujuguet P; Saniere L; der Aar EV; Maggio R; De Felice F; Marchese C; Dominici C; Tombolini V; Festuccia C; Marampon F
J Hematol Oncol; 2017 Oct; 10(1):161. PubMed ID: 28985758
[TBL] [Abstract][Full Text] [Related]
6. The role of ephrins and Eph receptors in cancer.
Surawska H; Ma PC; Salgia R
Cytokine Growth Factor Rev; 2004 Dec; 15(6):419-33. PubMed ID: 15561600
[TBL] [Abstract][Full Text] [Related]
7. Optimization of the Lead Compound NVP-BHG712 as a Colorectal Cancer Inhibitor.
Tröster A; DiPrima M; Jores N; Kudlinzki D; Sreeramulu S; Gande SL; Linhard V; Ludig D; Schug A; Saxena K; Reinecke M; Heinzlmeir S; Leisegang MS; Wollenhaupt J; Lennartz F; Weiss MS; Kuster B; Tosato G; Schwalbe H
Chemistry; 2023 Apr; 29(23):e202203967. PubMed ID: 36799129
[TBL] [Abstract][Full Text] [Related]
8. AMPK inhibitor compound C suppresses cell proliferation by induction of apoptosis and autophagy in human colorectal cancer cells.
Yang WL; Perillo W; Liou D; Marambaud P; Wang P
J Surg Oncol; 2012 Nov; 106(6):680-8. PubMed ID: 22674626
[TBL] [Abstract][Full Text] [Related]
9. Eph receptor interclass cooperation is required for the regulation of cell proliferation.
Jurek A; Genander M; Kundu P; Catchpole T; He X; Strååt K; Sabelström H; Xu NJ; Pettersson S; Henkemeyer M; Frisén J
Exp Cell Res; 2016 Oct; 348(1):10-22. PubMed ID: 27565439
[TBL] [Abstract][Full Text] [Related]
10. Eph receptor and ephrin function in breast, gut, and skin epithelia.
Perez White BE; Getsios S
Cell Adh Migr; 2014; 8(4):327-38. PubMed ID: 25482622
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cell differentiation by Eph receptor and ephrin signaling.
Wilkinson DG
Cell Adh Migr; 2014; 8(4):339-48. PubMed ID: 25482623
[TBL] [Abstract][Full Text] [Related]
12. EphB/EphrinB receptors and Wnt signaling in colorectal cancer.
Clevers H; Batlle E
Cancer Res; 2006 Jan; 66(1):2-5. PubMed ID: 16397205
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting Eph kinase activity may not be "Eph"ective for cancer treatment.
Herington AC; Mertens-Walker I; Lisle JE; Maharaj M; Stephenson SA
Growth Factors; 2014 Dec; 32(6):207-13. PubMed ID: 25413947
[TBL] [Abstract][Full Text] [Related]
14. Complex expression patterns of Eph receptor tyrosine kinases and their ephrin ligands in colorectal carcinogenesis.
Herath NI; Spanevello MD; Doecke JD; Smith FM; Pouponnot C; Boyd AW
Eur J Cancer; 2012 Mar; 48(5):753-62. PubMed ID: 21852108
[TBL] [Abstract][Full Text] [Related]
15. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway.
Noren NK; Foos G; Hauser CA; Pasquale EB
Nat Cell Biol; 2006 Aug; 8(8):815-25. PubMed ID: 16862147
[TBL] [Abstract][Full Text] [Related]
16. EphrinB-EphB signaling regulates spinal pain processing via PKCγ.
Zhou XL; Zhang CJ; Wang Y; Wang M; Sun LH; Yu LN; Cao JL; Yan M
Neuroscience; 2015 Oct; 307():64-72. PubMed ID: 26318332
[TBL] [Abstract][Full Text] [Related]
17. Disruption of ephrin B/Eph B interaction results in abnormal cochlear innervation patterns.
Zhou CQ; Lee J; Henkemeyer MJ; Lee KH
Laryngoscope; 2011 Jul; 121(7):1541-7. PubMed ID: 21647913
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of the radiosensitizing effect of a selective FGFR inhibitor (JNJ-42756493) for rectal cancer.
Verstraete M; Debucquoy A; Gonnissen A; Dok R; Isebaert S; Devos E; McBride W; Haustermans K
BMC Cancer; 2015 Dec; 15():946. PubMed ID: 26675289
[TBL] [Abstract][Full Text] [Related]
19. EphrinB-mediated reverse signalling controls junctional integrity and pro-inflammatory differentiation of endothelial cells.
Liu H; Devraj K; Möller K; Liebner S; Hecker M; Korff T
Thromb Haemost; 2014 Jul; 112(1):151-63. PubMed ID: 24522257
[TBL] [Abstract][Full Text] [Related]
20. Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway.
Vucicevic L; Misirkic M; Janjetovic K; Vilimanovich U; Sudar E; Isenovic E; Prica M; Harhaji-Trajkovic L; Kravic-Stevovic T; Bumbasirevic V; Trajkovic V
Autophagy; 2011 Jan; 7(1):40-50. PubMed ID: 20980833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
